Key result
Pathogenic MYH7 variant is linked to arrhythmogenic LV cardiomyopathy with extensive mid-wall fibrosis.
Why the study?
Arrhythmogenic left ventricular cardiomyopathy remains an underrecognized and diagnostically challenging phenotype of arrhythmogenic cardiomyopathy.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
This case expands the phenotypic spectrum of the pathogenic MYH7 p.Arg723Cys variant to include arrhythmogenic left ventricular cardiomyopathy, demonstrating the critical role of cardiac MRI and genetic testing in diagnosis and sudden cardiac death risk stratification.
-associated cardiomyopathy and highlights the critical role of multimodal imaging and genetic testing in establishing the diagnosis of ALVC and guiding risk stratification. CLINICAL IMPACT: Arrhythmogenic left ventricular cardiomyopathy (ALVC) remains an underrecognized and diagnostically challenging phenotype of arrhythmogenic cardiomyopathy. This case describes a potential association between the pathogenic MYH7 p.Arg723Cys variant and ALVC, expanding the phenotypic spectrum of MYH7-associated cardiomyopathy beyond its more established associations with hypertrophic and dilated cardiomyopathy. The case highlights the complementary roles of cardiac magnetic resonance imaging and genetic testing in identifying ALVC when conventional evaluation is inconclusive. Recognition of extensive myocardial fibrosis together with a pathogenic genetic variant may also provide important information for arrhythmic risk stratification, consideration of primary-prevention implantable cardioverter-defibrillator therapy, genetic counseling, and cascade testing of first-degree relatives.
No takes yet. Share an insight, caveat, or question.
Chaudhry et al. (2026) conducted a case report in Arrhythmogenic left ventricular cardiomyopathy (ALVC) associated with MYH7 p.Arg723Cys mutation (n=1). MYH7 p.Arg723Cys (c.2167C>T) pathogenic missense variant evaluated by cardiac magnetic resonance imaging and genetic testing was evaluated on Diagnosis of arrhythmogenic left ventricular cardiomyopathy (ALVC) and arrhythmic risk stratification. The pathogenic MYH7 p.Arg723Cys variant was associated with arrhythmogenic left ventricular cardiomyopathy featuring extensive mid-wall fibrosis and an LVEF of 41% in a 58-year-old man.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: